NP1118980.RAhQoJun1-19aJ0Dlrri G37doo-yrcihshARB4Q-F3CA
type: Nanopublication
has assertion: NP1118980.RAhQoJun1-19aJ0Dlrri G37doo-yrcihshARB4Q-F3CA130 assertion
has provenance: NP1118980.RAhQoJun1-19aJ0Dlrri G37doo-yrcihshARB4Q-F3CA130 provenance
has publication info: NP1118980.RAhQoJun1-19aJ0Dlrri G37doo-yrcihshARB4Q-F3CA130 publicationInfo
created: 2016-05-13T12:50:13+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP1118980.RAhQoJun1-19aJ0Dlrri G37doo-yrcihshARB4Q-F3CA130 assertion
type: Assertion
description: [Our results suggest that the absence of PTRF in prostate cancer cells contributes significantly to tumour progression and metastasis by promoting the angiogenesis and lymphangiogenesis potential of the cancer cells, and this could be exploited for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/24123650
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0